Home / Discovery of a novel CDK46 and HDAC dual-targeting agent for the treatment of hepatocellular carcinoma Discovery of a novel CDK46 and HDAC dual-targeting agent for the treatment of hepatocellular carcinoma unknow ★ 5.0 · 7 reads Sign in to save this Request CodeZLIB.IO18509417 Published2022 Pages1 LanguageUnknown